Bank Pictet & Cie Europe AG Purchases 1,524 Shares of CME Group Inc. (NASDAQ:CME)

Bank Pictet & Cie Europe AG grew its holdings in CME Group Inc. (NASDAQ:CME) by 2.3% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 67,408 shares of the financial services provider’s stock after purchasing an additional 1,524 shares during the quarter. Bank Pictet & Cie Europe AG’s holdings in CME Group were worth $14,874,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of CME. Salomon & Ludwin LLC acquired a new stake in CME Group in the first quarter worth about $28,000. Y.D. More Investments Ltd acquired a new position in CME Group during the 2nd quarter valued at approximately $36,000. Thurston Springer Miller Herd & Titak Inc. raised its holdings in shares of CME Group by 62.2% in the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after buying an additional 74 shares during the last quarter. McClarren Financial Advisors Inc. lifted its stake in shares of CME Group by 66.1% during the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after buying an additional 78 shares during the period. Finally, Asset Dedication LLC grew its holdings in shares of CME Group by 515.2% during the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after buying an additional 170 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

CME opened at $226.17 on Wednesday. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $230.12. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. The firm’s fifty day simple moving average is $217.70 and its two-hundred day simple moving average is $208.53. The company has a market cap of $81.44 billion, a price-to-earnings ratio of 25.73, a PEG ratio of 7.76 and a beta of 0.55.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping the consensus estimate of $2.53 by $0.03. The company had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. CME Group’s quarterly revenue was up 12.7% on a year-over-year basis. During the same period in the previous year, the business earned $2.30 EPS. Equities analysts anticipate that CME Group Inc. will post 10.04 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were paid a dividend of $1.15 per share. The ex-dividend date was Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.03%. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

Wall Street Analyst Weigh In

Several analysts have weighed in on the company. Royal Bank of Canada reiterated a “sector perform” rating and set a $235.00 price target on shares of CME Group in a research note on Thursday, October 3rd. Bank of America increased their price target on shares of CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a report on Thursday, October 3rd. Piper Sandler increased their price objective on shares of CME Group from $225.00 to $240.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 8th. Oppenheimer boosted their target price on shares of CME Group from $228.00 to $245.00 and gave the company an “outperform” rating in a research report on Monday, October 14th. Finally, Citigroup lifted their price objective on CME Group from $240.00 to $250.00 and gave the company a “buy” rating in a research note on Thursday, October 3rd. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, CME Group has an average rating of “Hold” and an average target price of $220.07.

Insider Transactions at CME Group

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares in the company, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.30% of the company’s stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.